R1 RCM Inc. (RCM)
USD 14.31
(0.0%)
USD 14.31
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 426.2 Million USD | 196.57% |
| 2022 | 169.2 Million USD | -21.59% |
| 2021 | 223.2 Million USD | 50.1% |
| 2020 | 211.7 Million USD | -11.7% |
| 2019 | 139.6 Million USD | 1904.76% |
| 2018 | 8.4 Million USD | 175.0% |
| 2017 | -6.5 Million USD | -103.64% |
| 2016 | 308.39 Million USD | 382.93% |
| 2015 | -121.9 Million USD | -313.83% |
| 2014 | -36.68 Million USD | -81.74% |
| 2013 | 244.79 Million USD | 260.17% |
| 2012 | -177.82 Million USD | -408.86% |
| 2011 | 56.38 Million USD | 97.95% |
| 2010 | 28.47 Million USD | 32.53% |
| 2009 | 21.48 Million USD | 302.59% |
| 2008 | 5.33 Million USD | 545.34% |
| 2007 | 827 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 15.8 Million USD | 240.21% |
| 2024 Q1 | 112.8 Million USD | -29.47% |
| 2024 Q2 | 143.8 Million USD | -66.12% |
| 2023 Q4 | 141.6 Million USD | 26.43% |
| 2023 Q1 | 33.7 Million USD | 902.38% |
| 2023 Q3 | 112 Million USD | 20.82% |
| 2023 Q2 | 92.7 Million USD | 175.07% |
| 2023 FY | - USD | 196.57% |
| 2022 Q3 | 82.7 Million USD | 11.31% |
| 2022 FY | - USD | -21.59% |
| 2022 Q4 | -4.2 Million USD | -105.08% |
| 2022 Q1 | 76.6 Million USD | 52.59% |
| 2022 Q2 | 74.3 Million USD | -3.0% |
| 2021 Q1 | 64.2 Million USD | 116.16% |
| 2021 Q2 | 48.8 Million USD | -23.99% |
| 2021 Q3 | 60.7 Million USD | 24.39% |
| 2021 Q4 | 50.2 Million USD | -17.3% |
| 2021 FY | - USD | 50.1% |
| 2020 Q3 | 27.9 Million USD | 11.16% |
| 2020 FY | - USD | -11.7% |
| 2020 Q1 | 61 Million USD | 326.57% |
| 2020 Q2 | 25.1 Million USD | -58.85% |
| 2020 Q4 | 29.7 Million USD | 6.45% |
| 2019 FY | - USD | 1904.76% |
| 2019 Q1 | 35.3 Million USD | 805.13% |
| 2019 Q3 | 51.1 Million USD | -18.76% |
| 2019 Q2 | 62.9 Million USD | 78.19% |
| 2019 Q4 | 14.3 Million USD | -72.02% |
| 2018 Q3 | 22.5 Million USD | 30.81% |
| 2018 Q2 | 17.2 Million USD | 391.53% |
| 2018 FY | - USD | 175.0% |
| 2018 Q1 | -5.9 Million USD | -59.46% |
| 2018 Q4 | 3.9 Million USD | -82.67% |
| 2017 Q3 | 2.2 Million USD | 150.0% |
| 2017 Q1 | -4.9 Million USD | -117.81% |
| 2017 FY | - USD | -103.64% |
| 2017 Q4 | -3.7 Million USD | -268.18% |
| 2017 Q2 | -4.4 Million USD | 10.2% |
| 2016 Q3 | 64.63 Million USD | 210.03% |
| 2016 Q4 | 27.5 Million USD | -57.44% |
| 2016 Q1 | 291.79 Million USD | 1529.79% |
| 2016 FY | - USD | 382.93% |
| 2016 Q2 | -58.73 Million USD | -120.13% |
| 2015 Q1 | -45.59 Million USD | -675.99% |
| 2015 Q4 | 17.9 Million USD | 140.53% |
| 2015 Q3 | -44.17 Million USD | -13.47% |
| 2015 Q2 | -38.93 Million USD | 14.61% |
| 2015 FY | - USD | -313.83% |
| 2014 Q4 | 7.91 Million USD | -81.94% |
| 2014 Q3 | 43.83 Million USD | 271.55% |
| 2014 Q2 | 11.79 Million USD | 193.44% |
| 2014 Q1 | -12.62 Million USD | -129.68% |
| 2014 FY | - USD | -81.74% |
| 2013 Q1 | -38.65 Million USD | 79.83% |
| 2013 FY | - USD | 260.17% |
| 2013 Q3 | -40.87 Million USD | -112.94% |
| 2013 Q4 | 42.54 Million USD | 204.09% |
| 2013 Q2 | 315.83 Million USD | 917.14% |
| 2012 Q2 | 1.31 Million USD | -72.63% |
| 2012 Q3 | 6.4 Million USD | 387.75% |
| 2012 Q1 | 4.8 Million USD | -80.19% |
| 2012 Q4 | -191.6 Million USD | -3089.66% |
| 2012 FY | - USD | -408.86% |
| 2011 Q3 | 14.39 Million USD | -6.23% |
| 2011 Q4 | 24.23 Million USD | 68.4% |
| 2011 Q1 | 2.39 Million USD | -78.18% |
| 2011 FY | - USD | 97.95% |
| 2011 Q2 | 15.34 Million USD | 539.95% |
| 2010 FY | - USD | 32.53% |
| 2010 Q2 | 8.74 Million USD | 260.54% |
| 2010 Q4 | 10.99 Million USD | 73.95% |
| 2010 Q3 | 6.31 Million USD | -27.74% |
| 2010 Q1 | 2.42 Million USD | -72.97% |
| 2009 FY | - USD | 302.59% |
| 2009 Q2 | 3.88 Million USD | 460.84% |
| 2009 Q3 | 7.94 Million USD | 104.61% |
| 2009 Q4 | 8.97 Million USD | 12.97% |
| 2009 Q1 | 692 Thousand USD | -14.57% |
| 2008 Q3 | 4 Million USD | 0.0% |
| 2008 Q4 | 810 Thousand USD | -79.79% |
| 2008 FY | - USD | 545.34% |
| 2007 FY | - USD | 0.0% |
| 2000 Q4 | -4.2 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 186.56 Million USD | -128.448% |
| GE HealthCare Technologies Inc. | 3.56 Billion USD | 88.028% |
| Sharecare, Inc. | -67.25 Million USD | 733.717% |
| Progyny, Inc. | 64.46 Million USD | -561.134% |
| Aclarion, Inc. | -4.14 Million USD | 10393.659% |
| CareMax, Inc. | -590.46 Million USD | 172.181% |
| Simulations Plus, Inc. | 6.13 Million USD | -6851.558% |
| CareCloud, Inc. | -31.29 Million USD | 1462.097% |
| Forian Inc. | 2.75 Million USD | -15396.542% |
| Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | 8179.537% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | 8179.537% |
| Minerva Surgical, Inc. | -20.07 Million USD | 2223.25% |
| Omnicell, Inc. | 60.69 Million USD | -602.257% |
| Definitive Healthcare Corp. | -241.22 Million USD | 276.68% |
| Zhongchao Inc. | -4.9 Million USD | 8793.784% |
| Accolade, Inc. | -71.19 Million USD | 698.654% |
| Streamline Health Solutions, Inc. | -12.81 Million USD | 3425.531% |
| Ontrak, Inc. | -14.41 Million USD | 3056.437% |
| SOPHiA GENETICS SA | -70.7 Million USD | 702.829% |
| Spok Holdings, Inc. | 26.29 Million USD | -1520.717% |
| Privia Health Group, Inc. | 27.18 Million USD | -1467.949% |
| EUDA Health Holdings Limited | -8.3 Million USD | 5234.717% |
| HeartBeam, Inc. | 675 Thousand USD | -63040.741% |
| GeneDx Holdings Corp. | -136.46 Million USD | 412.326% |
| TruBridge, Inc. | -15.39 Million USD | 2869.151% |
| Nutex Health, Inc. | -14.58 Million USD | 3022.911% |
| Renalytix Plc | -28.52 Million USD | 1594.338% |
| Sharecare, Inc. | -67.25 Million USD | 733.717% |
| Health Catalyst, Inc. | -66.46 Million USD | 741.269% |
| 10x Genomics, Inc. | -205.11 Million USD | 307.79% |
| GoodRx Holdings, Inc. | 108.82 Million USD | -291.642% |
| SCWorx Corp. | -3.97 Million USD | 10822.835% |
| Schrödinger, Inc. | -171.89 Million USD | 347.941% |
| HealthEquity, Inc. | 282.41 Million USD | -50.912% |
| HealthStream, Inc. | 59.58 Million USD | -615.257% |
| MSP Recovery, Inc. | -69.22 Million USD | 715.709% |
| Augmedix, Inc. | -17.68 Million USD | 2510.497% |
| BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | -21.94% |
| Ontrak, Inc. | -14.41 Million USD | 3056.437% |
| SHL Telemedicine Ltd. | 3.28 Million USD | -12879.996% |
| CareCloud, Inc. | -31.29 Million USD | 1462.097% |
| Premier, Inc. | 286.08 Million USD | -48.975% |
| Certara, Inc. | 23.84 Million USD | -1687.452% |
| GeneDx Holdings Corp. | -136.46 Million USD | 412.326% |
| OneMedNet Corporation | -11.97 Million USD | 3660.344% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | -21.94% |
| EUDA Health Holdings Limited | -8.3 Million USD | 5234.717% |
| HeartBeam, Inc. | 675 Thousand USD | -63040.741% |
| CareCloud, Inc. | -31.29 Million USD | 1462.097% |
| Mangoceuticals, Inc. | -9.18 Million USD | 4738.897% |
| CareMax, Inc. | -590.46 Million USD | 172.181% |
| Healthcare Triangle, Inc. | -4.1 Million USD | 10484.99% |
| National Research Corporation | 45.98 Million USD | -826.824% |
| Aclarion, Inc. | -4.14 Million USD | 10393.659% |
| OptimizeRx Corporation | -21.3 Million USD | 2100.15% |